1. Home
  2. VYNE vs BWEN Comparison

VYNE vs BWEN Comparison

Compare VYNE & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • BWEN
  • Stock Information
  • Founded
  • VYNE 2003
  • BWEN N/A
  • Country
  • VYNE United States
  • BWEN United States
  • Employees
  • VYNE N/A
  • BWEN N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • BWEN Industrial Machinery/Components
  • Sector
  • VYNE Health Care
  • BWEN Industrials
  • Exchange
  • VYNE Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • VYNE 41.9M
  • BWEN 39.1M
  • IPO Year
  • VYNE 2018
  • BWEN N/A
  • Fundamental
  • Price
  • VYNE $2.49
  • BWEN $1.85
  • Analyst Decision
  • VYNE Strong Buy
  • BWEN Strong Buy
  • Analyst Count
  • VYNE 2
  • BWEN 3
  • Target Price
  • VYNE $6.88
  • BWEN $5.17
  • AVG Volume (30 Days)
  • VYNE 70.8K
  • BWEN 153.1K
  • Earning Date
  • VYNE 11-07-2024
  • BWEN 11-13-2024
  • Dividend Yield
  • VYNE N/A
  • BWEN N/A
  • EPS Growth
  • VYNE N/A
  • BWEN N/A
  • EPS
  • VYNE N/A
  • BWEN 0.14
  • Revenue
  • VYNE $493,000.00
  • BWEN $156,169,000.00
  • Revenue This Year
  • VYNE $28.30
  • BWEN N/A
  • Revenue Next Year
  • VYNE N/A
  • BWEN $25.42
  • P/E Ratio
  • VYNE N/A
  • BWEN $13.21
  • Revenue Growth
  • VYNE 39.27
  • BWEN N/A
  • 52 Week Low
  • VYNE $1.57
  • BWEN $1.52
  • 52 Week High
  • VYNE $3.43
  • BWEN $4.65
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 40.82
  • BWEN 53.51
  • Support Level
  • VYNE $2.34
  • BWEN $1.74
  • Resistance Level
  • VYNE $2.69
  • BWEN $1.87
  • Average True Range (ATR)
  • VYNE 0.19
  • BWEN 0.10
  • MACD
  • VYNE -0.04
  • BWEN 0.01
  • Stochastic Oscillator
  • VYNE 13.79
  • BWEN 37.93

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through three operating segments namely Heavy Fabrications, Gearing and Industrial Solutions.

Share on Social Networks: